Business
DATATRAK Announces Settlement of Patent Litigation
DATATRAK Announces Settlement of Patent Litigation.
About this update from Datatrak International, Inc.
[{"type":"text","content":"\nDATATRAK Announces Settlement of Patent Litigation\n\nDATATRAK Announces Settlement of Patent Litigation\n\n\n CLEVELAND, OH--(Marketwired - January 06, 2016) - \n DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical™\ntechnologies and delivering related services for the clinical trials industry, today announced that it has entered into a settlement agreement with Medidata Solutions, Inc. to resolve all existing patent litigation between the parties.Under the terms of the settlement agreement, the parties agreed to dismiss the claims against each other in the lawsuits pending in the U.S. District Court for the Northern District of Ohio and the U.S. District Court for the District of New Jersey. Neither party made any payment as part of the settlement. DATATRAK and Medidata also agreed to mutual covenants not to sue with respect to the patents-in-suit and related patents.\n About DATATRAK\n \n DATATRAK International, the leader in developing cloud-based, unified dClinical™ platform, is a worldwide technology and consulting company serving the clinical trials industry. The company delivers a portfolio of software solutions that safely accelerate clinical research, from Concept to Cure®.Join DATATRAK Thought Leaders:\n \n Twitter\n \n \n LinkedIn\n \n \n SlideShare\n \n \n The DATATRAK Blog\n \n Tweet: #DATATRAK announces patent litigation settlement http://ow.ly/WGuRB\n About \n \n DATATRAK\n \n DATATRAK International is a worldwide technology and services company delivering Unified dClinical™ solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK's Clinical and Consulting Services group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK ONE® software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Phase I -- Phase IV drug and device studies in multiple languages...